Restrictive Fluid Therapy in Septic Shock – Evidence Summary

Primary Recommendation

• In adult ICU patients with septic shock, a restrictive fluid‑resuscitation strategy (prioritizing vasopressors and smaller fluid volumes) does not increase mortality compared with a liberal strategy and therefore should be adopted, guided by continuous assessment of fluid responsiveness to limit fluid overload and its complications. 1

Evaluation of Fluid Responsiveness

• Before giving additional fluid boluses, clinicians should evaluate the patient’s fluid response after the initial resuscitation phase in those with persistent shock. 1
• A fluid‑challenge test is recommended for most patients, except when obvious hypovolemia is present (e.g., active hemorrhage). 1
• Fluid responsiveness should be re‑assessed repeatedly because only about 50 % of patients initially respond, and of those responders only ≈ 50 % maintain a positive response after 30 minutes. 1
• Even in patients who initially respond, titration of further fluids must be cautious, particularly when intravascular filling pressures are high or extravascular lung water is elevated. 1

Risks of Excess Fluid Accumulation

• Fluid overload is harmful in critically ill patients, contributing to pulmonary edema, renal dysfunction, and increased intra‑abdominal pressure. 1
• Giving fluids to non‑responders leads to hemodilution without a corresponding rise in cardiac output, thereby reducing oxygen delivery. 1
• Restricting fluids in non‑responders helps keep the total fluid balance low and mitigates the above risks. 1

Hemodynamic Monitoring to Guide Fluid Therapy

• Clinicians should weigh the potential benefit against the risk for each fluid administration decision. 1
• Guidance can be based on dynamic indices (e.g., pulse‑pressure variation, stroke‑volume variation) or on static trends (e.g., arterial pressure and heart‑rate trajectories). 1

Microcirculatory Assessment (Emerging Tool)

• Visualization of the sublingual microcirculation may uncover persistent microvascular hypoperfusion after macrocirculatory resuscitation, but current evidence does not show a clear outcome benefit. 1

Practical Emphasis

• The central principle is rigorous, repeated evaluation of fluid responsiveness, rather than adherence to a predetermined fluid volume target. 1

Evidence‑Based Sepsis Fluid Resuscitation Guidelines

Fluid Choice

• Crystalloids are recommended as the first‑line intravenous fluid for initial resuscitation and subsequent volume replacement in adult patients with sepsis or septic shock (strong recommendation). 2

• Balanced crystalloids may be preferred over normal saline because they are associated with a lower risk of renal dysfunction, although the evidence is not quantified in the cited sources. (moderate recommendation). 3

Fluid Administration Strategy

• A dynamic fluid‑challenge approach should be employed, delivering fluid only while objective hemodynamic parameters (e.g., improvement in cardiac output, pulse pressure variation, or stroke‑volume variation) continue to rise; administration is stopped once the response plateaus to prevent unnecessary volume accumulation. (strong recommendation). 4

• Hemodynamic response can be monitored using either dynamic indices (such as pulse‑pressure variation or stroke‑volume variation) or static indices (arterial pressure and heart‑rate trends) to guide ongoing fluid delivery. (moderate recommendation). 5

Albumin Consideration

• Albumin may be added to crystalloids when a patient requires a large volume of crystalloid resuscitation, but this is a weak recommendation supported by low‑quality evidence; albumin should be reserved for cases with substantial crystalloid needs rather than used routinely. 2

Fluids to Avoid

• Hydroxyethyl starches should never be used for intravascular volume replacement in sepsis or septic shock, as high‑quality evidence demonstrates an increased requirement for renal replacement therapy. (strong recommendation). 3

• Gelatin solutions are not recommended; crystalloids should be preferred for fluid resuscitation in septic patients. (moderate recommendation). 4

Early Vasopressor Integration

• Norepinephrine is the first‑choice vasopressor, with a target mean arterial pressure of 65 mm Hg, to be initiated early (preferably within the first hour) when initial fluid therapy does not achieve blood‑pressure goals. (strong recommendation). 5

Early Sepsis Fluid Resuscitation – Evidence‑Based Recommendations

Reassessment After the Initial Crystalloid Bolus

• In adult patients with suspected early sepsis who have received a 500–1000 mL crystalloid bolus, clinicians should reassess hemodynamics within 10–60 minutes, evaluating mean arterial pressure (target ≥ 65 mmHg), heart rate (should trend downward if fluid‑responsive), capillary refill time/skin mottling, lactate concentration (repeat if elevated), and urine output (target ≥ 0.5 mL/kg/h)【6】.

Fluid Responsiveness Assessment and Vasopressor Initiation

• If MAP remains < 65 mmHg after the initial bolus, norepinephrine should be started immediately (target MAP ≥ 65 mmHg) rather than giving additional large‑volume fluids【6】.
• Prior to any further fluid administration, fluid responsiveness must be confirmed using dynamic tests such as passive leg raise, pulse pressure variation ≥ 13 % (in mechanically ventilated patients with tidal volume ≥ 8 mL/kg), or stroke volume variation【6】.
• Additional fluid should be given only to patients who are fluid‑responsive; giving fluids to non‑responders is associated with hemodilution, reduced oxygen delivery, and increased risk of pulmonary edema and acute kidney injury【6】.

Maintenance Fluid Strategy When MAP Is Adequate

• When MAP is ≥ 65 mmHg after the initial bolus and there is no evidence of ongoing hypovolemia (e.g., persistent tachycardia, poor capillary refill, or rising lactate), no further bolus fluids are recommended【6】.
• Instead, transition to a maintenance crystalloid infusion of 1.0–1.5 mL/kg/h (approximately 75–100 mL/h for a 70‑kg adult)【6】.

Pitfalls to Avoid in Guiding Fluid Therapy

• Static hemodynamic measures such as central venous pressure or inferior vena cava diameter should not be used alone to guide fluid therapy because they poorly predict fluid responsiveness【6】.